Maaind
PrivateLast Round
Seed
Feb 22, 2022
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Maaind is a neurotechnology company that develops a multimodal AI platform for real-time emotion and stress recognition to improve human well-being and performance.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Maaind Comparables
Compare Maaind with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arctop | 80% | |
| Nefesh AI | 78% | |
| Sonde Health | 73% | |
Maaind Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 22, 2022 | ||||
| Accelerator | Feb 25, 2021 |
Maaind Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Tech Center | Accelerator |
| Startup Autobahn | Accelerator |
| Entrepreneurs First | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 48% MoM.
- May 2, 2025
Monthly visitors grew 4483% MoM, from 24 to 1.1K.
Maaind Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Maaind's valuation, stock price, and market status.